Alumis Inc. (ALMS) vs Geron Corporation (GERN)
A side-by-side comparison of Alumis Inc. and Geron Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMS
Alumis Inc.
$6.84HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
GERN
Geron Corporation
$1.21HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALMS vs GERN
growth of $100 · dividends reinvested · last 2yALMS -48.6% (-28.3%/yr)GERN -71.5% (-46.6%/yr)ALMS compounded faster over this window
ALMS GERN
ALMS vs GERN: by the numbers
- •ALMS is the larger company ($844M vs $776M market cap).
- •Both run net losses; GERN's is the smaller (-34.17% vs -5933.45% net margin).
Metrics side by side
Valuation
| Metric | ALMS | GERN |
|---|---|---|
| P/S ratio | 114.12 | 3.79 |
| P/B ratio | 1.87 | 3.55 |
Profitability
| Metric | ALMS | GERN |
|---|---|---|
| Gross margin | 88.23% | 97.42% |
| Operating margin | -1776.32% | -29.28% |
| Net margin | -5933.45% | -34.17% |
| ROE | -97.08% | -31.97% |
| ROIC | -94.76% | -8.34% |
Growth (annualized)
| Metric | ALMS | GERN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 247.85% |
| Total return CAGR (5Y) | N/A | -1.87% |
Go deeper
Dig into the metrics
Alumis ROEGeron ROEAlumis operating marginGeron operating marginAlumis revenue growthGeron revenue growthAlumis free cash flowGeron free cash flow
Alumis & Geron appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.